NanoString Technologies
OverviewSuggest Edit
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system; nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. It also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels.
| Type | Public | |
| Founded | 2003 | |
| HQ | Seattle, WA, US | Map |
| Website | nanostring.com | |
| Employee Ratings | More | |
| Overall Culture | D- | More |
Recent NewsAll News
- Worldwide Industry for Spatial Genomics and Transcriptomics to 2030 - Players Include NanoString Technologies, S2 Genomics & Flagship Biosciences Among Others
- NanoString Technologies Announces Commencement of Public Offering of Common Stock
- NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
Key People/Management at NanoString Technologies
Brad Gray
President and Chief Executive Officer
J. Chad Brown
Senior Vice President, Sales and Marketing
Kathy Surace-Smith
Vice President, General Counsel and Corporate Secretary
Thomas Bailey
Chief Financial Officer
Joseph M. Beechem
Chief Science Officer & Senior Vice President, Research & Development
David W. Ghesquiere
Senior Vice President, Corporate and Business Development
NanoString Technologies Office Locations
NanoString Technologies has an office in Seattle
Seattle, WA, US (HQ)
530 Fairview Ave N #2000
NanoString Technologies Financials and Metrics
NanoString Technologies Revenue
NanoString Technologies's revenue was reported to be $117.32 m in FY, 2020
| USD | |
|---|---|
Revenue (FY, 2020) | 117.3m |
Gross profit (FY, 2020) | 64.9m |
Gross profit margin (FY, 2020), % | 55.3% |
Net income (FY, 2020) | (110.1m) |
EBIT (FY, 2020) | (88.0m) |
Market capitalization (1-Mar-2021) | 3.3b |
Closing stock price (1-Mar-2021) | 74.4 |
Cash (31-Dec-2020) | 411.8m |
EV | 3.1b |
NanoString Technologies's current market capitalization is $3.3 b.
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.1m | 34.6m | 27.0m | 23.1m | 25.0m | 28.6m | 27.7m | 30.3m | 30.6m | 26.6m | 21.1m |
Cost of goods sold | 7.2m | 8.2m | 7.3m | 7.7m | 8.6m | 9.3m | 8.7m | 9.6m | 10.9m | 11.0m | |
Gross profit | 10.9m | 26.4m | 19.7m | 15.4m | 16.4m | 19.3m | 19.0m | 20.7m | 19.7m | 15.6m | |
Gross profit Margin, % | 60% | 76% | 73% | 67% | 66% | 68% | 69% | 68% | 64% | 59% |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 5.4m | 40.6m | 28.8m | 15.6m | 24.3m | 21.2m | 84.1m | 33.4m | 23.4m | 155.6m | 168.4m |
Accounts Receivable | 16.7m | 18.5m | 18.3m | 16.3m | 17.4m | 18.5m | 18.1m | 19.0m | 19.5m | 21.2m | 22.0m |
Prepaid Expenses | 4.0m | 5.3m | 6.1m | 5.8m | 5.9m | 7.1m | 8.6m | 9.2m | 10.9m | 5.4m | 3.2m |
Inventories | 14.5m | 15.8m | 18.5m | 19.1m | 17.6m | 15.0m | 13.0m | 16.5m | 19.0m | 22.2m | 26.0m |
Annual
Quarterly
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (18.9m) | (23.4m) | (34.8m) | (19.2m) | (39.8m) | (56.3m) | (21.9m) | (41.9m) | (64.7m) | (38.6m) | (65.8m) |
Depreciation and Amortization | 814.0k | 1.7m | 2.5m | 928.0k | 2.0m | 3.0m | 1.2m | 2.4m | 3.6m | 1.2m | 2.8m |
Inventories | (837.0k) | (2.5m) | (5.9m) | 817.0k | 1.6m | 3.5m | (465.0k) | (4.4m) | (7.2m) | (2.7m) | (6.6m) |
Accounts Payable | (2.1m) | (392.0k) | (1.7m) | 716.0k | 1.1m | 1.3m | (1.9m) | (2.6m) | (2.0m) | (260.0k) | (2.8m) |
| USD | Q1, 2017 |
|---|---|
Debt/Equity | -15.6 x |
Debt/Assets | 0.4 x |
Financial Leverage | -34.8 x |
NanoString Technologies Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| NanoString Technologies Asia Pacific Limited | ||
| NanoString Technologies (Bejing) Co. Ltd. | ||
| NanoString Technologies Europe Limited | ||
| NanoString Technologies Germany GmbH | ||
| NanoString Technologies International | ||
| NanoString Technologies SAS | ||
| NanoString Technologies Singapore Pte Limited | ||
| NanoString Technologies Spain, S.L. |
NanoString Technologies Revenue Breakdown
NanoString Technologies revenue breakdown by business segment: 24.7% from Instruments, 41.1% from Consumables, 7.5% from In Vitro Diagnostic Kits, 9.3% from Service and 17.4% from Collaboration
NanoString Technologies revenue breakdown by geographic segment: 68.6% from Americas, 24.1% from Europe & Middle East and 7.3% from Asia Pacific
NanoString Technologies Cybersecurity Score
NanoString Technologies Environment, Social & Governance (ESG) Ratings
NanoString Technologies Online and Social Media Presence
5.72k Twitter followers
NanoString Technologies has 5.72k Twitter Followers. The number of followers has increased 1.1% month over month and increased 2.2% quarter over quarter
NanoString Technologies's Trends
Twitter Engagement Stats for @nanostringtech
1.9k
Tweets
1.4k
Following
5.7k
Followers
108
Tweets last 30 days
2.2
Avg. likes per Tweet
88.9%
Tweets with engagement
NanoString Technologies Company Culture
Overall Culture
D-
53/100
CEO Rating
C-
66/100
Compensation
C-
63/100
NanoString Technologies News and Updates
December 08, 2020
Worldwide Industry for Spatial Genomics and Transcriptomics to 2030 - Players Include NanoString Technologies, S2 Genomics & Flagship Biosciences Among Others
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Global Spatial Genomics and Transcriptomics Market: Focus on Product Type, Sample Type, Workflow, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
March 18, 2019
NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering of 4,500,000 shares of its common stock pursuant to its shelf regi…
January 07, 2019
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance —— Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers —
NanoString Technologies Blogs
March 01, 2021
A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering.
NanoString has an unparalleled and longstanding tradition of developing best in class cancer research tools, thanks to an extensive knowledge...
The post A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering. appeared first on Nanostring.
February 08, 2021
Of Mice and Men: The importance of Mouse Models in Research.
Many animals share common biology with humans, are affected by similar diseases, and may have a comparable response to certain...
The post Of Mice and Men: The importance of Mouse Models in Research. appeared first on Nanostring.
January 19, 2021
The Coronavirus Vaccine Ushers in Hope for 2021
Vaccines: biological agents eliciting an immune response to a specific antigen derived from an infectious disease-causing pathogen. The concept of a “vaccine” emerged in 1796, when Edward Jenner developed the first by subcutaneously inoculating smallpox virus into non-immune individuals. Vaccines [……
January 05, 2021
NanoString Proudly Introduces the new Furry, Slobbery, Four-Legged-Inspired Gene Expression Panel, a.k.a. the nCounter® Canine IO Panel.
It may have happened to you, as it happened to some of us here at NanoString®: the furry, four-legged trouble-making family member you just can’t stay mad at is sick, and the vet doesn’t know what is happening. Tests for […]
The post NanoString Proudly Introduces the new Furry, Slobbery, Four-Legged…
December 21, 2020
AMP-ed Up for Clinical Evaluation with GeoMx DSP
The Association for Molecular Pathology (AMP) joined the list of conferences to go virtual in 2020. NanoString was online with workshops highlighting uses for the groundbreaking GeoMx® Digital Spatial Profiler (DSP) for pathologists and their studies. The seminar “NanoString GeoMx® […]
The post AMP-…
December 07, 2020
SITC in Focus: CAR-T Cell Therapy
The Society for Immunotherapy of Cancer (SITC) held its annual meeting online this year. Notable were the presentations in New Approaches for CAR-T Cell Therapies: Technology Symposium Featuring GeoMx® Digital Spatial Profiler (DSP) and nCounter CAR-T Characterization Panel. Two speakers […]
The pos…
NanoString Technologies Frequently Asked Questions
When was NanoString Technologies founded?
NanoString Technologies was founded in 2003.
Who are NanoString Technologies key executives?
NanoString Technologies's key executives are Brad Gray, J. Chad Brown and Kathy Surace-Smith.
How many employees does NanoString Technologies have?
NanoString Technologies has 551 employees.
What is NanoString Technologies revenue?
Latest NanoString Technologies annual revenue is $117.3 m.
What is NanoString Technologies revenue per employee?
Latest NanoString Technologies revenue per employee is $212.9 k.
Who are NanoString Technologies competitors?
Competitors of NanoString Technologies include EKF Diagnostics, Klox Technologies and Viapath.
Where is NanoString Technologies headquarters?
NanoString Technologies headquarters is located at 530 Fairview Ave N #2000, Seattle.
Where are NanoString Technologies offices?
NanoString Technologies has an office in Seattle.
How many offices does NanoString Technologies have?
NanoString Technologies has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies